SNHG12 and nonpapillary renal cell carcinoma: SNHG12 was found to exert its regulatory effects through downregulating miR-129-5p, the target of which is murine double minute 4 (MDM4), which has been reported to be overexpressed in several cancers, including ccRCC (84).